Fig. 8: microRNA-708 (miR-708 predicted poor glioma patient prognosis and was negatively associated with enhancer of zeste homolog 2 (EZH2) expression. | Cell Death & Disease

Fig. 8: microRNA-708 (miR-708 predicted poor glioma patient prognosis and was negatively associated with enhancer of zeste homolog 2 (EZH2) expression.

From: Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma

Fig. 8

a We observed a negative relationship between miR-708 and EZH2 expression (left panel). In situ hybridization results showing miR-708 and EZH2 expression levels in glioma tissues (right panel). b Glioma patients with low miR-708 levels display worse overall survival rates than those with high levels of miR-708 in high-grade glioma patients. c The TCGA database revealed that low miR-708 levels display worse overall survival rates than those with high levels of miR-708 in low-grade glioma patients

Back to article page